Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial Evaluating the Pharmacokinetics, Safety and Preliminary Efficacy of EP-104IAR (Long-Acting Fluticasone Propionate) in Patients With Osteoarthritis of the Knee
Conditions
Interventions
EP-104IAR
Vehicle
Locations
3
Canada
Rebalance MD
Victoria, British Columbia, Canada
Centre for Studies in Family Medicine
London, Ontario, Canada
Fowler Kennedy Sports Medicine Clinic
London, Ontario, Canada
Start Date
April 1, 2016
Primary Completion Date
December 28, 2017
Completion Date
December 28, 2017
Last Updated
September 1, 2021
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Eupraxia Pharmaceuticals Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions